Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.
One place this happens is around the belly button, where tiny veins in the abdominal wall expand and become visible under the ...
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
Patients with celiac disease have double the incidence rate of chronic liver disease compared with those without this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results